From the Division of Medical Toxicology (AFM, SH, RO), Department of Emergency Medicine, The Icahn School of Medicine at Mount Sinai, New York, NY; Departments of Psychiatry and Neuroscience (GY, YLH), The Icahn School of Medicine at Mount Sinai, and James J Peters VA Medical Center, Bronx, NY; Department of Clinical, Toxicological and Food Sciences Analysis (MMB), School of Pharmaceutical Sciences of Ribeirão Preto, University of São Paulo, Brazil; Chemistry and Drug Metabolism (AJB, MAH), Intramural Research Program, National Institute on Drug Abuse, NIH, Baltimore, MD; Department of Oncological Sciences (GW), The Icahn School of Medicine at Mount Sinai, New York, NY; Department of Psychiatry (RS), Yale University School of Medicine, New Haven, CT; and Research Center (DJA), Centre Hospitalier de l'Université de Montréal, and Department of Psychiatry, University of Montreal, Montreal, Canada.

Send correspondence and reprint requests to Yasmin L. Hurd, PhD, Icahn School of Medicine at Mount Sinai, New York, NY 10029. E-mail: yasmin.hurd@mssm.edu.

Supported by a research grant from the National Institutes of Health grant DA027781 (YLH) and CTSA (UL1RR029887).

This content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute on Drug Abuse or the National Institutes of Health.

The authors declare no conflicts of interest.

Received October 02, 2014

Accepted January 11, 2015